Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
300009.SZ Stock Price Chart
Explore Anhui Anke Biotechnology (Group) Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300009.SZ price movements and trends.
300009.SZ Company Profile
Discover essential business fundamentals and corporate details for Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Oct 2009
Employees
2.65K
Website
https://www.ankebio.comCEO
Jian Ping Yao
Description
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.
300009.SZ Financial Timeline
Browse a chronological timeline of Anhui Anke Biotechnology (Group) Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 Aug 2025
Dividend declared on 23 May 2025
A dividend of ¥0.15 per share was announced, adjusted to ¥0.15. The dividend was paid on 23 May 2025.
Earnings released on 28 Apr 2025
EPS came in at ¥0.13 , while revenue for the quarter reached ¥628.75M .
Earnings released on 27 Mar 2025
EPS came in at ¥0.07 , while revenue for the quarter reached ¥614.76M .
Dividend declared on 17 Jan 2025
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 17 Jan 2025.
Earnings released on 24 Oct 2024
EPS came in at ¥0.11 , while revenue for the quarter reached ¥622.47M .
Earnings released on 27 Aug 2024
EPS came in at ¥0.12 , while revenue for the quarter reached ¥637.01M .
Dividend declared on 27 May 2024
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 27 May 2024.
Earnings released on 25 Apr 2024
EPS came in at ¥0.13 , while revenue for the quarter reached ¥650.48M .
Earnings released on 28 Mar 2024
EPS came in at ¥0.12 , while revenue for the quarter reached ¥836.86M .
Earnings released on 24 Oct 2023
EPS came in at ¥0.16 , while revenue for the quarter reached ¥734.10M .
Earnings released on 23 Aug 2023
EPS came in at ¥0.13 , while revenue for the quarter reached ¥693.11M .
Dividend declared on 19 May 2023
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 19 May 2023.
Earnings released on 27 Apr 2023
EPS came in at ¥0.11 , while revenue for the quarter reached ¥594.17M .
Earnings released on 27 Mar 2023
EPS came in at ¥0.07 , while revenue for the quarter reached ¥624.38M .
Earnings released on 25 Oct 2022
EPS came in at ¥0.15 , while revenue for the quarter reached ¥625.96M .
Earnings released on 24 Aug 2022
EPS came in at ¥0.11 , while revenue for the quarter reached ¥547.37M .
Dividend declared on 13 May 2022
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 13 May 2022.
Earnings released on 27 Apr 2022
EPS came in at ¥0.11 , while revenue for the quarter reached ¥533.36M , missing expectations by -83.28%.
Earnings released on 30 Mar 2022
EPS came in at -¥0.14 , while revenue for the quarter reached ¥621.37M .
Earnings released on 28 Oct 2021
EPS came in at ¥0.11 , while revenue for the quarter reached ¥578.15M .
Earnings released on 19 Aug 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥484.42M .
Dividend declared on 14 May 2021
A dividend of ¥0.17 per share was announced, adjusted to ¥0.17. The dividend was paid on 14 May 2021.
Stock split effective on 14 May 2021
Shares were split 6 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Apr 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥549.00M .
Earnings released on 8 Apr 2021
EPS came in at ¥0.08 , while revenue for the quarter reached ¥484.83M .
Earnings released on 28 Oct 2020
EPS came in at ¥0.08 , while revenue for the quarter reached ¥440.39M .
300009.SZ Stock Performance
Access detailed 300009.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.